ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Limits on measuring the impact of rapid antimicrobial susceptibility testing (AST)
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
The 37,000-year view: Infections in Eurasia
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
The 6 meanings of “Lack of Access” (UNSLAP)
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet









